Cala Health, a wearable neuromodulation therapy startup focused on chronic diseases, has closed a $50 million Series C financing round.
Novartis, Baird Capital, LifeSci Venture Partners, TriVentures and other unnamed backers participated, as did returning investors JJDC, Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital and GV.
WHAT THEY DO
Stanford University...
Cala Health, a stealthy startup out of Stanford University has raised $18 million according to an SEC filing. MedCityNews first spotted the story. Johnson & Johnson Development Corporation, Lux Capital and Lightstone Ventures all contributed to the round.
Cala Health hasn't sought much press and declined to comment to MobiHealthNews. But the SEC document reveals that the company was...
